CareDx Inc. has appointed John W. Hanna as its new President and Chief Executive Officer, and member of the Company?s Board of Directors, effective April 15, 2024. Hanna brings to CareDx over two decades of executive leadership at the intersection of new technology development and revenue growth in the molecular diagnostics and life sciences tools industries. Hanna previously served as Chief Executive Officer of Apton Biosystems Inc., where he led the development of a high throughput next-generation sequencing (NGS) platform for liquid biopsy and other clinical applications.

The company was acquired by Pacific Biosciences of California Inc. in August 2023, where he served as Vice President of Corporate Development. Hanna previously spent ten years at Veracyte Inc., an oncology diagnostics company in the fields of thyroid, lung, breast, and prostate cancer, where he held numerous roles including Chief Commercial Officer and Vice President of Marketing. Prior to Veracyte, Hanna held leadership roles at Humana and IBM.